相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?
Alessandro Rizzo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma
Yifei Dai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy
Alessandro Rizzo et al.
FUTURE ONCOLOGY (2021)
Systematic Analysis Identifies a Specific RNA-Binding Protein-Related Gene Model for Prognostication and Risk-Adjustment in HBV-Related Hepatocellular Carcinoma
Maoshi Li et al.
FRONTIERS IN GENETICS (2021)
Review article: new therapeutic interventions for advanced hepatocellular carcinoma
Saroja Bangaru et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
Wei Li et al.
AGING-US (2020)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8
Kaori Iino et al.
CANCER SCIENCE (2020)
Harnessing big 'omics' data and AI for drug discovery in hepatocellular carcinoma
Bin Chen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Pinero et al.
CELLS (2020)
BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining
Ke-Wei Bi et al.
FRONTIERS IN ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data
Jianfeng Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies
Tony Yao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Comprehensive analysis of autophagy-related prognostic genes in breast cancer
Jianguo Lai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
RNA-binding proteins in tumor progression
Hai Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx
Lixing Li et al.
FRONTIERS IN MEDICINE (2020)
Development and validation of a prognostic model for kidney renal clear cell carcinoma based on RNA binding protein expression
Yuzhu Xiang et al.
Aging-US (2020)
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
Bufu Tang et al.
CELL COMMUNICATION AND SIGNALING (2020)
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
James J. Harding et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
NOL12 Repression Induces Nucleolar Stress-Driven Cellular Senescence and Is Associated with Normative Aging
Marta Pinho et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma A Multicenter Study From China
Xin-Fei Xu et al.
JAMA SURGERY (2019)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Immune checkpoint therapy in liver cancer
Feng Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
RNA-binding proteins control gene expression and cell fate in the immune system
Martin Turner et al.
NATURE IMMUNOLOGY (2018)
Post-transcriptional regulation of immune responses by RNA binding proteins
Takashi Mino et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2018)
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Ming Yi et al.
MOLECULAR CANCER (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts
Linjie Zhao et al.
GENOME BIOLOGY (2018)
Nol12 is a multifunctional RNA binding protein at the nexus of RNA and DNA metabolism
Daniel D. Scott et al.
NUCLEIC ACIDS RESEARCH (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability
Katharina E. Cosker et al.
NATURE NEUROSCIENCE (2016)
RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway
Yasuhiro Murakawa et al.
NATURE COMMUNICATIONS (2015)
Recent advances in the surgical treatment of hepatocellular carcinoma
Zenichi Morise et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity
M. P. Tschan et al.
ONCOGENE (2008)
分享论文
